Literature DB >> 22917636

A new low-volume isosmotic polyethylene glycol solution plus bisacodyl versus split-dose 4 L polyethylene glycol for bowel cleansing prior to colonoscopy: a randomised controlled trial.

Paola Cesaro1, Cesare Hassan, Cristiano Spada, Lucio Petruzziello, Giovanna Vitale, Guido Costamagna.   

Abstract

BACKGROUND: 4-L polyethylene glycol preparations are effective for colon cleansing before colonoscopy. However, large volume and unpleasant taste reduce tolerability and acceptability limiting patient compliance. A new isosmotic low-volume polyethylene glycol preparation with citrates and simethicone plus bisacodyl has been developed to improve patient compliance and tolerability. AIM: To compare the efficacy of 2 different regimens of preparation vs a split-dose of polyethylene glycol solution. PATIENTS AND METHODS: In this randomised, blinded, comparative study, 153 patients were allocated to 3 arms. Arm 1 (n=52) received bisacodyl and 2-L polyethylene glycol with citrates and simethicone the day before the procedure. Arm 2 (n=50) received bisacodyl the day before and 2-L polyethylene glycol with citrates and simethicone on the day of colonoscopy. Control group (n=51) received a split-dose of 4-L polyethylene glycol. Cleansing was evaluated according to Ottawa scale.
RESULTS: The mean Ottawa score was not different in the 3 groups. Excellent cleansing was observed more frequently in arm 2 (70%) than in controls (49%) (p<0.05). No serious adverse events were observed in the 3 regimens. The willingness to repeat the same bowel preparation was superior in arms 1 and 2 than in controls (p<0.001).
CONCLUSIONS: New low-volume preparations seem to be as effective as the split 4-L polyethylene glycol regimen, showing a better tolerability and acceptability.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917636     DOI: 10.1016/j.dld.2012.07.011

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Bisacodyl plus split 2-L polyethylene glycol-citrate-simethicone improves quality of bowel preparation before screening colonoscopy.

Authors:  Flavio Valiante; Angelo Bellumat; Manuela De Bona; Michele De Boni
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Advances in colonoscopy.

Authors:  Nicholas Tutticci; Michael J Bourke
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

3.  Simethicone decreases bloating and improves bowel preparation effectiveness: a systematic review and meta-analysis.

Authors:  Muhammad Moolla; Jerry T Dang; Ashley Shaw; Thuc Nhi Tran Dang; Chunhong Tian; Shahzeer Karmali; Richard Sultanian
Journal:  Surg Endosc       Date:  2019-08-26       Impact factor: 4.584

4.  The Efficacy of Simethicone With Polyethylene Glycol for Bowel Preparation: A Systematic Review and Meta-Analysis.

Authors:  Xin Liu; Mufa Yuan; Zhen Li; Sujuan Fei; Guodong Zhao
Journal:  J Clin Gastroenterol       Date:  2021-07-01       Impact factor: 3.174

5.  The Effectiveness of Personalized Bowel Preparation Using a Smartphone Camera Application: A Randomized Pilot Study.

Authors:  Jae Won Jung; Jongha Park; Gi Jung Jeon; Young Soo Moon; Sung Yuon Yang; Tae Oh Kim; Eui Tay Jung; Hee-Cheol Kim
Journal:  Gastroenterol Res Pract       Date:  2017-08-08       Impact factor: 2.260

6.  A low-volume polyethylene glycol solution was associated with an increased suboptimal bowel preparation rate but had similar recommendations for an early repeat colonoscopy, procedure times, and adenoma detection rates.

Authors:  Sam C Hankins; Bryan B Brimhall; Vineel Kankanala; Gregory L Austin
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Same-day single-dose vs large-volume split-dose regimens of polyethylene glycol for bowel preparation: A systematic review and meta-analysis.

Authors:  Hui Pan; Xiao-Ling Zheng; Chao-Ying Fang; Lan-Zai Liu; Jian-Su Chen; Chao Wang; Yu-Dai Chen; Jian-Min Huang; Yu-Shen Zhou; Li-Ping He
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.